1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Trial in Progress: A Phase 3, Randomized, Double-Blind, Active-Control Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naive Adult Patients With Myelofibrosis (MANIFEST-3)

MPN - 555

Trial in Progress: A Phase 3, Randomized, Double-Blind, Active-Control Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naive Adult Patients With Myelofibrosis (MANIFEST-3)

John Mascarenhas

Poster Presenter: John Mascarenhas

$Thumbnail for Trial in Progress: QUINTESSENTIAL-2, a Phase 3 Study of Arlocabtagene Autoleucel vs Standard of Care in Adult Patients With Relapsed/Refractory Multiple Myeloma Exposed to Lenalidomide$

MM - 1092

Trial in Progress: QUINTESSENTIAL-2, a Phase 3 Study of Arlocabtagene Autoleucel vs Standard of Care in Adult Patients With Relapsed/Refractory Multiple Myeloma Exposed to Lenalidomide

Eyal Lebel

Poster Presenter: Eyal Lebel

Thumbnail for Triplet vs Quadruplet Induction Regimens in Transplant-Eligible and Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials

MM - 315

Triplet vs Quadruplet Induction Regimens in Transplant-Eligible and Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials

Elias Tayar

Poster Presenter: Elias Tayar

$Thumbnail for True Extramedullary Versus Paraskeletal/Paramedullary Disease as Determinants of CAR-T Outcomes in Relapsed or Refractory Multiple Myeloma$